Browse by Uncontrolled Keywords
Number of items: 6.
2009
Goldacre, B;
(2009)
Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes.
BMJ (Clinical research ed), 339.
b4949.
ISSN 0959-8138
DOI: https://doi.org/10.1136/bmj.b4949
2008
Al-Marzouki, S;
Roberts, I;
Evans, S;
Marshall, T;
(2008)
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.
Lancet, 372 (9634).
p. 201.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(08)61060-0
Full text not available from this repository.
2007
Goldacre, B;
(2007)
Benefits and risks of homoeopathy.
Lancet, 370 (9600).
pp. 1672-1673.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(07)61706-1
Full text not available from this repository.
2006
Fletcher, O;
Johnson, N;
Palles, C;
Dos Santos Silva, I;
McCormack, V;
Whittaker, J;
Ashworth, A;
Peto, J;
(2006)
Inconsistent association between the STK15 f31I genetic polymorphism and breast cancer risk.
Journal of the National Cancer Institute, 98 (14).
pp. 1014-1018.
ISSN 0027-8874
DOI: https://doi.org/10.1093/jnci/djj268
Full text not available from this repository.
2003
Colhoun, HM;
McKeigue, PM;
Smith, GD;
(2003)
Problems of reporting genetic associations with complex outcomes.
Lancet, 361 (9360).
pp. 865-872.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(03)12715-8
Full text not available from this repository.
2002
Petticrew, M;
Bell, R;
Hunter, D;
(2002)
Influence of psychological coping on survival and recurrence in people with cancer: systematic review.
BMJ, 325 (7372).
p. 1066.
ISSN 1468-5833
DOI: https://doi.org/10.1136/bmj.325.7372.1066